论文部分内容阅读
目的:探讨糖尿病性白内障术中前房注射曲安奈德的临床效果。方法:采用随机对照的方法,将80例糖尿病性白内障随机分为两组,实验组41例,采用小切口白内障摘除人工晶体植入术,术毕前房注入曲安奈德2 mg;对照组39例,术式同实验组,术毕前房不注入曲安奈德。观察术后角膜水肿、角膜内皮细胞密度、前房渗出、后囊混浊,眼压并发症等情况。结果:两组角膜水肿、前房渗出、房水闪辉、后囊混浊与对照组相比较有统计学意义(P<0.05),眼压、角膜内皮细胞密度、瞳孔黏连无统计学意义(P>0.05)。结论:术中前房注射曲安奈德可以有效地减少糖尿病性白内障患者术后并发症的发生,临床效果稳定可靠。
Objective: To investigate the clinical effect of injecting triamcinolone acetonide in anterior chamber in diabetic cataract surgery. Methods: Eighty diabetic diabetic cataract patients were randomly divided into two groups. In the experimental group, 41 cases were treated with small incision cataract extraction and intraocular lens implantation, and the anterior chamber was injected with triamcinolone acetonide 2 mg. The control group 39 Cases, surgical procedures with the experimental group, anterior chamber surgery is not injected triamcinolone acetonide. Postoperative corneal edema, corneal endothelial cell density, anterior chamber exudation, posterior capsule opacification, intraocular pressure complications and so on. Results: Corneal edema, exudation in the anterior chamber, shine in the aqueous humor and posterior capsular opacity in the two groups were significantly different from those in the control group (P <0.05). The intraocular pressure, corneal endothelial cell density and pupil adhesion were not statistically significant (P> 0.05). Conclusion: Intraoperative anterior chamber injection of triamcinolone acetonide can effectively reduce the incidence of postoperative complications in patients with diabetic cataract, the clinical effect is stable and reliable.